Cycloastragenol Production Cost Reports

The report provides a detailed analysis essential for establishing a Cycloastragenol production plant. It encompasses all critical aspects necessary for Cycloastragenol production, including the cost of Cycloastragenol production, Cycloastragenol plant cost, Cycloastragenol production costs, and the overall Cycloastragenol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cycloastragenol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cycloastragenol, a natural triterpenoid derived from Astragalus membranaceus, is industrially used primarily in anti-ageing dietary supplements due to its ability to activate telomerase and potentially extend cellular lifespan. It is also incorporated in products supporting immune system health, cardiovascular wellness by reducing inflammation, and neuroprotection. In cosmetics, cycloastragenol is valued for its antioxidant effects that enhance skin elasticity and reduce wrinkles.

Advances in industrial production use enzymatic hydrolysis for efficient, large-scale production, making it suitable for pharmaceutical, nutraceutical, and cosmetic applications. Additionally, ongoing research explores its benefits in anti-inflammatory, anti-cancer, and bone health treatments, positioning cycloastragenol as a promising compound across multiple health-related industries.

Cycloastragenol market growth is driven primarily by increasing consumer demand for natural anti-ageing and health-promoting supplements, fuelled by rising global health consciousness and an expanding geriatric population concerned with age-related health issues. The compound’s recognised benefits in enhancing telomerase activity, immune function, and overall cellular health boost its appeal in nutraceuticals, pharmaceuticals, and cosmetics.

Additional drivers include ongoing research revealing new therapeutic applications, growing disposable incomes, and heightened adoption in regions like North America and the Asia Pacific, where traditional medicine practices and advanced healthcare infrastructure support market expansion. Industrial cycloastragenol procurement is influenced by the variability in raw plant materials, primarily Astragalus membranaceus, which can differ due to geographic and climatic conditions. The complexity and cost of extraction technologies, such as supercritical CO2 extraction and solvent-based methods, also impact availability and price.

Raw Material for Cycloastragenol Production

According to the Cycloastragenol production plant project report, the raw material for Cycloastragenol production includes Astragaloside IV.

Production Process of Cycloastragenol

The extensive Cycloastragenol production cost report consists of the following major industrial production process:

1. Production via Astragaloside IV: The production process of cycloastragenol commonly starts with Astragaloside IV, which is dissolved in an acidic methanol solution (e.g., 10% HCl in methanol), followed by stirring the reaction mixture at room temperature for several days. The reaction mixture is then concentrated under reduced pressure at low temperature to avoid degradation. The concentrate undergoes liquid-liquid extraction with aqueous sodium bicarbonate and ethyl acetate to separate desired components. The organic phase is washed, dried, concentrated, and the crude product is purified by column chromatography using a chloroform/methanol gradient. Finally, residual solvents are displaced with ethanol under reduced pressure to yield purified cycloastragenol.

Properties of Cycloastragenol

Cycloastragenol is a naturally occurring tetracyclic triterpenoid sapogenin with the molecular formula C30H50O5 and a molecular weight of 490.7 g/mol. It appears as a white to almost white powder or crystalline solid with a melting point around 241-245 degree Celsius. The compound has low solubility in water but is soluble in solvents like dimethylformamide (DMF), dimethyl sulfoxide (DMSO), and ethanol, with solubilities of 25 mg/ml in DMF, 3 mg/ml in DMSO, and 10 mg/ml in ethanol.

Cycloastragenol exhibits optical activity with a specific rotation between +45° to +60° (c = 1 in methanol). Its physical density is around 1.20 g/cm3 (predicted). It has multiple hydroxyl groups and a steroidal-like tetracyclic ring structure contributing to its biological activities, including telomerase activation and anti-ageing effects. It has no formal charge and a topological polar surface area near 90.2 Ų, with several stereocentres indicating a complex, chiral structure.